Chernett discloses 5.11% in Airsculpt Technologies (AIRS) stake holding
Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G
Rhea-AI Filing Summary
Jorey Chernett has filed a Schedule 13G reporting a significant passive stake in Airsculpt Technologies, Inc. He reports beneficial ownership of 3,188,767 shares of Airsculpt common stock, representing 5.11% of the outstanding class as of the filing date. Chernett has sole power to vote and to dispose of all 3,188,767 shares, with no shared voting or dispositive power disclosed.
He certifies that the shares were not acquired and are not held for the purpose of changing or influencing control of Airsculpt, but instead are held on a passive basis consistent with Schedule 13G requirements.
Positive
- None.
Negative
- None.
FAQ
What ownership did Jorey Chernett report in Airsculpt Technologies (AIRS)?
Jorey Chernett reported beneficial ownership of 3,188,767 shares of Airsculpt Technologies, Inc. common stock on a Schedule 13G filing.
Is Jorey Chernett’s stake in Airsculpt Technologies considered passive or activist?
Chernett certifies that the securities were not acquired and are not held for the purpose of changing or influencing control of Airsculpt, indicating a passive investment under Schedule 13G.
What type of securities in Airsculpt Technologies does the Schedule 13G cover?
The Schedule 13G covers common stock of Airsculpt Technologies, Inc., identified by CUSIP number 009496100.
Where is Airsculpt Technologies, Inc. headquartered according to this filing?
The filing lists Airsculpt Technologies, Inc.’s principal executive offices at 1111 Lincoln Rd., Ste. 802, Miami Beach, FL 33139.